Novel highly active FSM-16 supported molybdenum catalyst for hydrotreatment. [electronic resource]
By: Contributor(s): Producer: 20090123Description: 5310-1 p. digitalISSN:- 1359-7345
Publication Type: Journal Article
There are no comments on this title.
-
1281
Polycyclic aromatic hydrocarbon metabolic network in Mycobacterium vanbaalenii PYR-1.
by Kweon, Ohgew -
1282
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.
-
1283
HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-I.
by Hung, Chien-Hui -
1284
Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study.
by Wedderburn, Catherine J -
1285
Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders.
by Hagemeier, J -
1286
Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension.
by Sinclair, Alexandra J -
1287
Collagen IV and basement membrane at the evolutionary dawn of metazoan tissues.
by Fidler, Aaron L -
1288
KIF5A mutations cause an infantile onset phenotype including severe myoclonus with evidence of mitochondrial dysfunction.
by Duis, Jessica -
1289
Contribution of Family Relatedness to Neurobehavioral Comorbidities in Idiopathic Childhood Epilepsies.
by Almane, Dace N -
1290
The ansacarbamitocins: polar ansamitocin derivatives.
by Snipes, Carl E -
1291
Phylogenetic relationships among arecoid palms (Arecaceae: Arecoideae).
by Baker, William J -
1292
Superselective neck dissection: rationale, indications, and results.
by Suárez, Carlos -
1293
Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review.
by Paleri, Vinidh -
1294
Cognition and brain development in children with benign epilepsy with centrotemporal spikes.
by Garcia-Ramos, Camille -
1295
Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine.
by Ghione, E -
1296
New molecular diagnostic methods in head and neck cancer.
by Rodrigo, Juan Pablo -
1297
Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction.
by Bax, Matthijs -
1298
Effects of Depth of Propofol and Sevoflurane Anesthesia on Upper Airway Collapsibility, Respiratory Genioglossus Activation, and Breathing in Healthy Volunteers.
by Simons, Jeroen C P -
1299
Cognitive phenotypes in childhood idiopathic epilepsies.
by Hermann, Bruce P -
1300
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
by Wachtell, Kristian
Novel highly active FSM-16 supported molybdenum catalyst for hydrotreatment.
APA
Garg S., Bhaskar T., Soni K., Muthu Kumaran G., Muto A., Sakata Y. & Murali Dhar G. (20090123). Novel highly active FSM-16 supported molybdenum catalyst for hydrotreatment. : Chemical communications (Cambridge, England).
Chicago
Garg Shelu, Bhaskar Thallada, Soni Kapil, Muthu Kumaran Gnanamani, Muto Akinori, Sakata Yusaku and Murali Dhar Gudimella. 20090123. Novel highly active FSM-16 supported molybdenum catalyst for hydrotreatment. : Chemical communications (Cambridge, England).
Harvard
Garg S., Bhaskar T., Soni K., Muthu Kumaran G., Muto A., Sakata Y. and Murali Dhar G. (20090123). Novel highly active FSM-16 supported molybdenum catalyst for hydrotreatment. : Chemical communications (Cambridge, England).
MLA
Garg Shelu, Bhaskar Thallada, Soni Kapil, Muthu Kumaran Gnanamani, Muto Akinori, Sakata Yusaku and Murali Dhar Gudimella. Novel highly active FSM-16 supported molybdenum catalyst for hydrotreatment. : Chemical communications (Cambridge, England). 20090123.